Back

Obesity and antithrombotic drugs: does body size matter?

2 November 2023 (14:20 - 14:40)
Organised by: Logo
Seminar Presentation Part of: Antithrombotic therapy in special populations Cardiovascular Pharmacotherapy Open Access EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy WG on Cardiovascular Pharmacotherapy

About the speaker

Photo
Associate Professor Erik Lerkevang Grove

Aarhus University Hospital, Aarhus (Denmark)

3 More presentations in this session

Presentation thumbnail
Antithrombotic drugs in chronic kidney disease: tackling an unmet therapeutic need
Professor D. Prisco (Florence, IT)
Presentation thumbnail
Pharmacogenomics for personalized antithrombotic drug management
Doctor E. Magavern (London, GB)
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
Antithrombotic therapy in special populations

The Event

Event poster

EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

2 November 2023 14:20 CET
You may be interested in
thumbnail
Congress Presentation
Impact of obesity on other drug therapy
31 August 2024
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025
thumbnail
Congress Presentation
Impact of body mass index on outcomes in european patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term Registry (AFGen LT)
30 August 2020
thumbnail
Congress Presentation
Direct oral anticoagulants compared to warfarin in morbidly obese patients on anticoagulation: a systematic review and meta-analysis
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources